Beyond semaglutide and tirzepatide, where might we find the next GLP 1 based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar People feel gaslit #tirzepatide #semaglutide . , One of the biggest mistakes I see is assuming that if someone cannot tolerate a GLP 1, there are no other options. Thats